Yourgene Health is currently developing its first infectious disease test – a molecular PCR-based COVID-19 assay. The Research Use Only version will be available by the end of June 2020, shortly followed by a CE marked in vitro diagnostic kit in July 2020.
The Yourgene Health Clarigene™ Sars-CoV-2 test (96) is a PCR-based COVID-19 assay to detect SARS-CoV-2 virus RNA targets to confirm the presence of the virus.
The target includes the E region of the genome, Nucleocapsid gene and human RNaseP.
The kit includes mastermix, primer & probe sets, and assay controls. The test is compatible with RNA extracted from a nasopharyngeal swab.
The Clarigene™ Sars-CoV-2 test can be run on a range of qPCR platforms, including ABI 7500.
- Low false negative results* ensures reliable and accurate results
- Minimal hands on time with turnaround time of 2.5 hours
- Enhanced scalable throughput available